GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NUTEX Investments PLC (BUD:NUTEX) » Definitions » Earnings per Share (Diluted)

NUTEX Investments (BUD:NUTEX) Earnings per Share (Diluted) : Ft1.13 (TTM As of Dec. 2023)


View and export this data going back to 1996. Start your Free Trial

What is NUTEX Investments Earnings per Share (Diluted)?

NUTEX Investments's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was Ft1.29. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was Ft1.13.

NUTEX Investments's EPS (Basic) for the six months ended in Dec. 2023 was Ft1.29. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was Ft1.13.

NUTEX Investments's EPS without NRI for the six months ended in Dec. 2023 was Ft1.30. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was Ft1.14.

During the past 12 months, NUTEX Investments's average EPS without NRIGrowth Rate was 25.80% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 46.60% per year.

During the past 13 years, NUTEX Investments's highest 3-Year average EPS without NRI Growth Rate was 82.40% per year. The lowest was -59.10% per year. And the median was 40.90% per year.


NUTEX Investments Earnings per Share (Diluted) Historical Data

The historical data trend for NUTEX Investments's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NUTEX Investments Earnings per Share (Diluted) Chart

NUTEX Investments Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.91 0.36 0.10 0.89 1.13

NUTEX Investments Semi-Annual Data
Dec13 Jun14 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 0.24 0.65 -0.16 1.29

Competitive Comparison of NUTEX Investments's Earnings per Share (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, NUTEX Investments's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NUTEX Investments's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NUTEX Investments's PE Ratio distribution charts can be found below:

* The bar in red indicates where NUTEX Investments's PE Ratio falls into.



NUTEX Investments Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

NUTEX Investments's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(171.124-0)/150.811
=1.13

NUTEX Investments's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(195.902-0)/146.759
=1.33

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was Ft1.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


NUTEX Investments  (BUD:NUTEX) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


NUTEX Investments Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of NUTEX Investments's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


NUTEX Investments (BUD:NUTEX) Business Description

Traded in Other Exchanges
N/A
Address
Telepes u. 53., Budapest, HUN, 1147
NUTEX Investments PLC operates as a drug manufacturer in Hungary. The company is engaged in production of products that focuses on health, vitality, and natural ingredients.

NUTEX Investments (BUD:NUTEX) Headlines

No Headlines